Image

Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer

Investigation of an Investigational Medication for Metastatic Pancreatic Cancer After Prior Treatment

Recruiting
18-80 years
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates metastatic pancreatic cancer. The purpose of this study is to understand how an investigational medication affects this condition.

Researchers are evaluating the safety and potential effects of the investigational medication. They are looking to see how it may work in patients who have not responded to previous treatments.

  • Who can participate: Adults aged 18 to 80 years with advanced or metastatic pancreatic cancer who have previously been treated with specific chemotherapy regimens may participate. Participants must meet certain health criteria and agree to study terms.
  • Study details: Participants will take an investigational medication to assess its effects. Some may receive a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.
Print
Study details
    Metastatic Pancreatic Cancer

NCT05766748

Cantex Pharmaceuticals

17 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.